NEW YORK (GenomeWeb News) - Illumina today reported a 54 percent boost in third-quarter revenue as a profit swung to a loss due to charges associated with its acquisition of sequencing startup Avantome.
For the quarter ended Sept. 30, Illumina reported revenues of $150.3 million, a 54 percent increase over $97.5 million in the third quarter of 2007 and its 29th consecutive quarter of revenue growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Sponsored by

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.